info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
Home » Healthcare » Spinal Fusion Devices Market Size & Growth Trends - 2030

Spinal Fusion Devices Market By Product (Thoracolumbar Devices (Anterior Lumbar Plates, Pedicle Screw and Rods, Others), Cervical Fixation Devices (Anterior Cervical Plates, Hook Fixation Systems, Others), Interbody Fusion Devices), By Disease Type (Degenerative Disc, Complex Deformity, Trauma & Fractures, Others), By Surgery (Open Spine Surgery, Minimally Invasive Spine Surgery), By End-User (Hospitals, Speciality Clinics, Others), By Size, Share, Growth, Global Industry Analysis Report, Forecast, 2021-2030

Published On: Jun-2022   |   Base Year: 2021   |   No Of Pages: 140   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 77989482

Industry Report and Statistics (Facts & Figures) - Number of Procedue Conducted by Type & End-users

The global spinal fusion devices market will witness a robust CAGR of 3.83%, valued at $6.86 billion in 2021, expected to appreciate and reach $9.63 billion by 2030, confirms Strategic Market Research. North America has the largest industry size, with a revenue share of over 41% in 2020. Spinal fusion is a surgery in which a surgeon permanently connects two vertebrae in the spine, eliminating motion between them. Spinal fusion generally uses a fluoroscopic C-Arm device, pedicle screws, and anterior interbody cages or spacers. Two types of spinal fusion surgery are performed worldwide – posterolateral gutter fusion and lumbar fusion. Spinal fusion surgeries are frequently performed worldwide. According to a study, 1.62 million spinal surgeries are performed annually in the United States of America. Around 350,000 lumbar interbody fusion surgeries are performed every year in the country. 85.5% of the performed lumbar interbody fusion surgeries were anterior, while the rest were posterior.

The first spinal surgery was recorded in the 7th century. In 1908, the first lumbar surgery was performed. Spinal fusion became a common surgical procedure in 1941. In 1985, disc decompression was achieved by partially removing disc material through the skin. In 1986, instruments that were used in eye surgery were redesigned for minimally invasive spine procedures. The first laser spinal surgery was done in 1990, and the precision of the laser used in spinal surgery was improved in 1992. Spinal fusion relieves pain to patients who do not respond well to traditional treatment methods. A patient’s unstable spine can be stabilized by spinal fusion. The procedure could help individuals perform certain activities they could not do before the surgery. It can treat various conditions like scoliosis, degenerative disc, etc., and has a high success rate.

Spinal Fusion Devices Market Infographics

Market Drivers - The increasing presence of Spinal Disorders, Emergence of Robotic Spinal Fusion Surgeries

  • The number of patients suffering from spinal disorders increases due to various lifestyle factors like diet and smoking. According to the NCBI, 28.1% of the population in the world suffers from spinal disorders. 53.1% reported lumbar spine disorders, while 27.1% reported cervical spine disorders. The spinal fusion devices segment trend has shifted positively due to a rising geriatric population and an increase in people who suffer from spinal disorders.

 

  • The increased usage of surgical robots for spinal fusion helps shift the global spinal fusion devices market trends upwards. Surgical robots have a greater success rate when performing minimally invasive surgery, which increases their demand. According to a study, for a minimally invasive transforaminal lumbar interbody fusion, the success rate ranges from 60% to 70%, with 80% of patients satisfied with the procedure. For a MI PLIF (posterior lumbar interbody fusion) procedure, the procedure is 90% to 95% successful.

Overall Market share of the global Spinal Fusion Device Market

Restraints

  • The high costs of surgery and the instruments hinder the industry growth to a great extent. Spinal fusion surgeries generally cost from $14,000 to $150,000. According to an NCBI study, anterior lumbar interbody fusion costs around $ 76,000, while posterior or transforaminal lumbar interbody fusion costs $ 66,000. The spinal fusion devices have high costs. The need to purchase support instruments for spinal fusion hinders the growth.

 

Opportunities - New Surgery Methods

  • New surgical methods can help boost spine surgery products, spinal non-fusion devices, and spinal fusion devices. Different types of spinal surgeries like posterolateral gutter fusion surgery, PLIF(posterior lumbar interbody fusion) surgery, transforaminal lumbar interbody fusion (TLIF) surgery, anterior/posterior lumbar fusion surgery, and anterior lumbar interbody fusion (ALIF) surgery can be used to treat isthmic spondylolisthesis, spinal stenosis, fractures, and tumors, which are rising in plethora in recent years. According to a study, spinal stenosis affects 8 to 11% of the American population, with 2.4 million Americans expected to be diagnosed with the disease in 2021. Spinal stenosis commonly affects people over 50 years old. Multilevel spinal fusion, minimally invasive spinal fusion and Endoscopic ETDIF can also be possible with the advent of new technology.

 

End-user covered in the Spinal Fusion Device market

 

Market Analysis Of Different Segments Covered in the Report

Based on Product

  • Thoracolumbar Devices    

    • Anterior Lumbar Plates

    • Pedicle Screw and Rods

    • Others

  • Cervical Fixation Devices  

    • Anterior Cervical Plates

    • Hook Fixation Systems

    • Others

  • Interbody Fusion Devices 

 

Based on Disease Type

  • Trauma & Fractures

  • Complex Deformity

  • Degenerative Disc

  • Others

 

Based on Surgery

  • Minimally Invasive Spine Surgery

  • Open Spine Surgery

 

Based on End-User

  • Specialty Clinics

  • Hospitals

  • Others

 

Regional Coverage Analysis

North America

  • United States of America

  • Canada

  • Rest of North America

 

Europe

  • United Kingdom

  • Spain

  • France

  • Germany

  • Italy

  • Rest of Europe

 

Asia-Pacific

  • India

  • China

  • Japan

  • Rest of Asia-Pacific

 

LAMEA

  • Mexico

  • Argentina

  • Brazil

  • Saudi Arabia

  • South Africa

  • Rest of LAMEA

 

Regional coverage of the market

 

Segments Analysis & Insights

The thoracolumbar devices segment had the highest global industry share, with a revenue of over 55% in 2020. The increasing frequency of occurrence of spinal disorders such as excessive kyphosis, spinal stenosis, and vertebral fracture has increased the demand for thoracolumbar devices. According to a study, around 250,000 to 500,000 US residents have spinal stenosis symptoms, representing 1 in 1000 people over 65 years old and 1 in 200 people over 50 years old.

 

The cervical fixation devices segment is expected to grow the fastest with a CAGR of 7.22%. Due to the rise in cervical spondylosis in corporate professionals, the industry growth for cervical fixation devices has been boosted. According to an NCBI study, 13.76% of Chinese adults suffer from cervical spondylosis. There was a slight difference among urban, suburban, and rural populations, with 13.07%, 15.97%, and 12.25%, respectively. More females were observed to suffer from cervical spondylosis than males, with the prevalence in females being 16.51% compared to the prevalence in males being 10.49%.
 

The minimally invasive surgery segment had the largest global industry size, with a revenue of over 64% in 2020. Patients feel that open spine surgery is more painful, has increased complication risk and recovery time, and requires heavier sedation. According to a study, patients need 3 to 4 months to recover fully after open spine surgery, while according to another study, they can recover within two weeks after minimally invasive spine surgery.

 

The degenerative disc segment had the highest share, with a revenue valuation of over 42% in 2020. The growing complaints of lower back pain and neck pain in adults and the rise in the geriatric population have driven industry growth in this segment. According to an NCBI study, nearly 400 million (or 5.5%) of the world’s population suffer from degenerative disc disease. 8.6% of Europe’s population suffers from this disease, making it the continent with the highest population suffering from degenerative disc disease.

 

The ‘hospitals’ segment contributed the maximum share to the industry, with a revenue share of 64% in 2020. The growing demand for spinal fusion surgeries and the increased number of trained medical professionals have contributed to the segment’s growth.

 

North America is geographically the largest global spinal fusion devices market, with a revenue share of 55.41% in 2020. The increasing rate of sports injuries and fatal accidents, increasing old-age population, and growing spinal disorders are the main reasons for the growth in demand for spinal fusion devices. According to the National SCI Statistics Centre, approximately 18,000 new spinal cord injuries are reported annually in the USA. 38.6% of these cases are due to vehicular accidents, while 7.8% of the cases have been due to sports injuries since 2015.

 

Spinal Fusion Devices Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 6.86 billion

The revenue forecast in 2028

USD 9.63 billion

Growth rate

CAGR of approximately 3.83%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2028)

Segmentation

By Product, By Disease Type, By Surgery, By End-User, By Region

By Product

Cervical Fixation Devices, Thoracolumbar Devices, Interbody Fusion Devices.

By Disease Type

Degenerative Disc, Complex Deformity, Trauma & Fractures, Others

By Surgery

Open Spine Surgery, Minimally Invasive Spine Surgery

By End-User

Hospitals, Speciality Clinics, Others

By Region

Asia-Pacific North America, Europe, LAMEA

Country Scope

United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc.

Company Usability Profiles

Stryker, Xtant Medical Holdings, Inc.Zimmer Biomet, DePuy Synthes (a subsidiary of Johnson & Johnson, Inc.), B. Braun Melsungen AG, Medtronic, NuVasive, Inc., Orthofix Medical, Inc., Globus Medical, ATEC Spine, Inc., SeaSpine, Spinal Elements, Inc., Spine Wave, Inc., Captiva Spine, Inc., Spineology, Inc.,

 

Global Spinal Fusion Devices Market Competitive Landscape Analysis

The market is moderately competitive. Companies operating in the market use strategies such as mergers & acquisitions, regional expansions, partnerships, new product launches, and collaborations to obtain a substantial market share.

Some of the major players in the market are:

 

 

Recent Developments

  • In July 2021, Integrity Implants, Inc. announced its merger with Fusion Robotics, LLC to form Accelus. Both organizations believe that the merger will create opportunities for large-scale adoption of robotics in spinal surgery in both hospitals and ambulatory surgical centers by addressing cost and efficiency concerns.

 

  • In April 2021, Empirical Spine, Inc. announced the Breakthrough Device Designation (BDD) grant for its Limiflex™ Paraspinous Tension Band. Empirical Spine believes that the device’s potential benefits could help improve the quality of patients’ lives receiving spinal surgery through the BDD grant.

 

  • In September 2020, Royal Biologics announced the complete acquisition of FIBRINET from Vertical Spine LLC. The acquisition allows Royal Biologics to improve its increasing portfolio of autologous and live cellular solutions to support spinal and orthopedic fusion.

 

  • In September 2020, Spineology, Inc. announced the FDA grant of the OptiMesh Expandable Interbody Fusion System. Spineology believes that the FDA grant will enable more surgeons to perform interbody fusion through the smallest point of access in the spine.

 

  • In August 2020, WishBone, Inc. announced the acquisition of all assets of Back 2 Basics Direct (B2B) and Orbbö Surgical. Wishbone believes that the acquisitions would strengthen its market position and allow it to deliver highly differentiated and disruptive technologies across its pediatric implant portfolio.

 

Various Devices that Key Market Leaders Develop:

Name of the Product

Function

Key Player

EXPEDIUM VERSE Spine System

Complex Spine Surgeries include spinal fusion in a time- and cost-effective manner.

DePuy Synthes (a Johnson & Johnson subsidiary)

Aleutian Posterior-Lumbar Interbody System

Posterior lumbar interbody fusion (PLIF) surgery

Stryker

Biomet SpinalPak Non-Invasive Spine Fusion Stimulator System

Promotion of healing of the spine after spinal fusion

Zimmer Biomet

SpinalStim™

Treatment of failed fusion or after spinal fusion surgery

Orthofix Medical, Inc.

Aesculap Aeos

Microscopy for Spinal Fusion

B. Braun Melsungen AG

 

Frequently Asked Question About This Report

70% to 90% of all spinal fusion surgeries are successful.

A spinal fusion surgery costs from USD 14,000 to USD 150,000.

The global spinal fusion devices market is expected to grow at a compound annual growth rate (CAGR) of 3.83% from 2021 to 2030 to reach USD 9.63 billion by 2030.

The degenerative disc segment has the highest spinal fusion device market share, with a valuation of over 42% in 2020.

The minimally invasive surgery segment led the spinal fusion device market with a revenue share of over 64% in 2020.

The cervical fixation devices are expected to have the highest growth rate in the spinal implants and surgical devices market, with a CAGR of 7.22%.

New surgical methods can help new and existing players in the spinal implants and surgical devices market to enhance their market share.

The global spinal fusion devices market size was $6.86 Bn in 2021 and is predicted to reach $9.63 Bn by 2030, with a CAGR of 3.83% during 2021-2030.

.

Source   http://www.ncbi.nlm.nih.gov/

                  https://www.nscisc.uab.edu/

 

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1 Spinal Fusion Devices Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1 Market Snapshot

       4.2 Spinal Fusion Devices Market

              4.2.1      market, 2021 – 2030 (USD Million)

       4.3 Regional Business Analysis

              4.3.1      market, by region, 2021-2030 (USD Million)

       4.4 By Product Business Analysis

              4.4.1      market, By Product, 2021-2030 (USD Million)

       4.5 By Disease Type Business Analysis

              4.5.1      market, By Disease Type, 2021-2030 (USD Million)

       4.6 Surgery Business Analysis

              4.6.1      market, By Surgery, 2021-2030 (USD Million)

       4.6 End-user Business Analysis

              4.6.1      market, By End-user, 2021-2030 (USD Million)

       4.7 Value Chain Analysis

       4.8 Market Variable Analysis

              4.8.1      Market Drivers Analysis

              4.8.2      Market Restraints Analysis

       4.9 Business Environment Analysis Tool

              4.9.1      market PEST analysis

              4.9.2      market Porter’s analysis

       4.10 Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On Market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              End-user Analysis

              5.11.1.   Trends in End-user (2014-2020)

              5.11.2.   Trends in End-user (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By Region, By Country)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturers Manufacturing Sites, Area Served, Product

       6.3. Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Market: By Product Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Thoracolumbar Devices

              7.3.1. Thoracolumbar Devices market, 2021-2030 (USD Million)

                   7.3.1.1 Anterior Lumbar Plates market, 2021-2030 (USD Million)

                   7.3.1.2 Pedicle Screw and Rods market, 2021-2030 (USD Million)

                   7.3.1.3 Others market, 2021-2030 (USD Million)

  7.4. Cervical Fixation Devices

               7.4.1. Cervical Fixation Devices market, 2021-2030 (USD Million)

                    7.4.1.2 Anterior Cervical Plates market, 2021-2030 (USD Million)

                    7.4.1.3 Hook Fixation Systems market, 2021-2030 (USD Million)

                    7.4.1.4 Others market, 2021-2030 (USD Million)

  7.5. Interbody Fusion Devices

               7.5.1. Interbody Fusion Devices market, 2021-2030 (USD Million)

8. Market: By Disease Type Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Degenerative Disc

              8.3.1.     Degenerative Disc market, 2021-2030 (USD Million)

       8.4. Complex Deformity

              8.4.1.     Complex Deformity market, 2021-2030 (USD Million)

       8.5. Trauma & Fractures

              8.5.1.     Trauma & Fractures market, 2021-2030 (USD Million)

       8.6. Others

              8.6.1.     Others market, 2021-2030 (USD Million)

9. Market: By Surgery Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Open Spine Surgery

              9.3.1.     Open Spine Surgery market, 2021-2030 (USD Million)

       9.4. Minimally Invasive Spine Surgery

              9.4.1.     Minimally Invasive Spine Surgery market, 2021-2030 (USD Million)

10. Market: By End-user Segment Analysis

       10.1. Introduction

       10.2. Sales Volume & Revenue Analysis (2021-2030)

       10.4. Hospitals

              10.4.1.   Hospitals market, 2021-2030 (USD Million)

       10.5. Specialty Clinics

              10.5.1.   Specialty Clinics market, 2021-2030 (USD Million)

       10.5. Others

              10.5.1.   Others market, 2021-2030 (USD Million)

11. Market: Regional Outlook

       11.1 North America

              11.1.1.   North America market, By Product, 2021-2030 (USD Million)

              11.1.2.   North America market, By Disease Type, 2021-2030 (USD Million)

              11.1.3.   North America market, by End-user, 2021-2030 (USD Million)

              11.1.4.   North America market, by Country, 2021-2030 (USD Million)

       11.1.4.1. U.S.

                     11.1.4.1.1.   U.S. market, By Product, 2021-2030 (USD Million)

                     11.1.4.1.2.   U.S. market, By Disease Type, 2021-2030 (USD Million)

                     11.1.4.1.3.   U.S. market, by End-user, 2021-2030 (USD Million)

     11.1.4.2.  Canada

                     11.1.4.2.1.   Canada market, By Product, 2021-2030 (USD Million)

                     11.1.4.2.2.   Canada market, By Disease Type, 2021-2030 (USD Million)

                     11.1.4.2.3.   Canada market, by End-user, 2021-2030 (USD Million)

11.2. Europe

              11.2.1.   Europe market, By Product, 2021-2030 (USD Million)

              11.2.2.   Europe market, By Disease Type, 2021-2030 (USD Million)

              11.2.3.   Europe market, by End-user, 2021-2030 (USD Million)

              11.2.4.   Europe market, by country, 2021-2030 (USD Million)

    11.2.4.1    U.K.

                     11.2.4.1.1.   U.K. market, By Product, 2021-2030 (USD Million)

                     11.2.4.1.2.   U.K. market, By Disease Type, 2021-2030 (USD Million)

                     11.2.4.1.3.   U.K. market, by End-user, 2021-2030 (USD Million)

   11.2.4.2.           Germany

                     11.2.4.2.1.   Germany market, By Product, 2021-2030 (USD Million)

                     11.2.4.2.2.   Germany market, By Disease Type, 2021-2030 (USD Million)

                     11.2.4.2.3.   Germany market, by End-user, 2021-2030 (USD Million)

   11.2.4.3.           France

                     11.2.4.3.1.   France market, By Product, 2021-2030 (USD Million)

                     11.2.4.3.2.   France market, By Disease Type, 2021-2030 (USD Million)

                     11.2.4.3.3.   France market, by End-user, 2021-2030 (USD Million)

    11.2.4.4.          Rest of Europe

                     11.2.4.4.1.   Rest of Europe market, By Product, 2021-2030 (USD Million)

                     11.2.4.4.2.   Rest of Europe market, By Disease Type, 2021-2030 (USD Million)

                     11.2.4.4.3.   Rest of Europe market, by End-user, 2021-2030 (USD Million)

       11.3.              Asia Pacific

              11.3.1.   Asia Pacific market, By Product, 2021-2030 (USD Million)

              11.3.2.   Asia Pacific market, By Disease Type, 2021-2030 (USD Million)

              11.3.3.   Asia Pacific market, by End-user, 2021-2030 (USD Million)

              11.3.4.   Asia Pacific market, by country, 2021-2030 (USD Million)

   11.3.4.1.           China

                     11.3.4.1.1.   China market, By Product, 2021-2030 (USD Million)

                     11.3.4.1.2.   China market, By Disease Type, 2021-2030 (USD Million)

                     11.3.4.1.3.   China market, by End-user, 2021-2030 (USD Million)

   11.3.4.2.           India

                     11.3.4.2.1.   India market, By Product, 2021-2030 (USD Million)

                     11.3.4.2.2.   India market, By Disease Type, 2021-2030 (USD Million)

                     11.3.4.2.3.   India  market, by End-user, 2021-2030 (USD Million)

   11.3.4.3.           Japan

                     11.3.4.3.1.   Japan market, By Product, 2021-2030 (USD Million)

                     11.3.4.3.2.   Japan market, By Disease Type, 2021-2030 (USD Million)

                     11.3.4.3.3.   Japan market, by End-user, 2021-2030 (USD Million)

   11.3.4.4.           South Korea

                     11.3.4.4.1.   South Korea market, By Product, 2021-2030 (USD Million)

                     11.3.4.4.2.   South Korea market, By Disease Type, 2021-2030 (USD Million)

                     11.3.4.4.3.   South Korea market, by End-user, 2021-2030 (USD Million)

11.3.4.5.              Rest of ASIA PACIFIC

                     11.3.4.5.1.   Rest of ASIA PACIFIC market, By Product, 2021-2030 (USD Million)

                     11.3.4.5.2.   Rest of ASIA PACIFIC market, By Disease Type, 2021-2030 (USD Million)

                     11.3.4.5.3.   Rest of ASIA PACIFIC market, by End-user, 2021-2030 (USD Million)

       11.4.              Latin America

              11.4.1.   Latin America market, By Product, 2021-2030 (USD Million)

              11.4.2.   Latin America market, By Disease Type, 2021-2030 (USD Million)

              11.4.3.   Latin America market, by End-user, 2021-2030 (USD Million)

              11.4.4.   Latin America market, by country, 2021-2030 (USD Million)

11.4.4.1.              Brazil

                     11.4.4.1.1.   Brazil market, By Product, 2021-2030 (USD Million)

                     11.4.4.1.2.   Brazil market, By Disease Type, 2021-2030 (USD Million)

                     11.4.4.1.3.   Brazil market, by End-user, 2021-2030 (USD Million)

11.4.4.2.              Mexico

                     11.4.4.2.1.   Mexico market, By Product, 2021-2030 (USD Million)

                     11.4.4.2.2.   Mexico market, By Disease Type, 2021-2030 (USD Million)

                     11.4.4.2.3.   Mexico market, by End-user, 2021-2030 (USD Million)

                     11.4.4.3.       Rest of the Latin America

                     11.4.4.3.1.   Rest of the Latin America market, By Product, 2021-2030 (USD Million)

                     11.4.4.3.2.   Rest of the Latin America market, By Disease Type, 2021-2030 (USD Million)

                     11.4.4.3.3.   Rest of the Latin America market, by End-user, 2021-2030 (USD Million)

       11.5.              MEA

              11.5.1.   MEA market, By Product, 2021-2030 (USD Million)

              11.5.2.   MEA market, By Disease Type, 2021-2030 (USD Million)

              11.5.3.   MEA market, by End-user, 2021-2030 (USD Million)

              11.5.4.   MEA market, by Region, 2021-2030 (USD Million)

 

12. Competitive Landscape

       12.1 DePuy Synthes

              12.1.1.   Company overview

              12.1.2.   Financial performance

              12.1.3.   Product Portfolio Analysis

              12.1.4.   Business Strategy & Recent Development

       12.2. Stryker

              12.2.1.   Company overview

              12.2.2.   Financial performance

              12.2.3.   Product Portfolio Analysis

              12.2.4.   Business Strategy & Recent Development

       12.3. Zimmer Biomet

              12.3.1.   Company overview

              12.3.2.   Financial performance

              12.3.3.   Product Portfolio Analysis

              12.3.4.   Business Strategy & Recent Development

       12.4. Orthofix Medical, Inc

              12.4.1.   Company overview

              12.4.2.   Financial performance

              12.4.3.   Product Portfolio Analysis

              12.4.4.   Business Strategy & Recent Development

       12.5. B. Braun Melsungen AG

              12.5.1.   Company overview

              12.5.2.   Financial performance

              12.5.3.   Product Portfolio Analysis

              12.5.4.   Business Strategy & Recent Development

       12.6. Medtronic

              12.6.1.   Company overview

              12.6.2.   Financial performance

              12.6.3.   Product Portfolio Analysis

              12.6.4.   Business Strategy & Recent Development

       12.7. NuVasive, Inc

              12.7.1.   Company overview

              12.7.2.   Financial performance

              12.7.3.   Product Portfolio Analysis

              12.7.4.   Business Strategy & Recent Development

       12.8. Globus Medical

              12.8.1.   Company overview

              12.8.2.   Financial performance

              12.8.3.   Product Portfolio Analysis

              12.8.4.   Business Strategy & Recent Development

       12.9. ATEC Spine, Inc

              12.9.1.   Company overview

              12.9.2.   Financial performance

              12.9.3.   Product Portfolio Analysis

              12.9.4.   Business Strategy & Recent Development

       12.10. Captiva Spine, Inc

              12.10.1. Company overview

              12.10.2. Financial performance

              12.10.3. Product Portfolio Analysis

              12.10.4. Business Strategy & Recent Development

       12.11. SeaSpine

              12.11.1. Company overview

              12.11.2. Financial performance

              12.11.3. Product Portfolio Analysis

              12.11.4. Business Strategy & Recent Development

       12.12. Spinal Elements, Inc

              12.12.1. Company overview

              12.12.2. Financial performance

              12.12.3. Product Portfolio Analysis

              12.12.4. Business Strategy & Recent Development

       12.13. Spine Wave, Inc

              12.13.1. Company overview

              12.13.2. Financial performance

              12.13.3. Product Portfolio Analysis

              12.13.4. Business Strategy & Recent Development

       12.14. Spineology, Inc

              12.14.1. Company overview

              12.14.2. Financial performance

              12.14.3. Product Portfolio Analysis

              12.14.4. Business Strategy & Recent Development

       12.15. Xtant Medical Holdings, Inc

              12.15.1. Company overview

              12.15.2. Financial performance

              12.15.3. Product Portfolio Analysis

              12.15.4. Business Strategy & Recent Development

      

 

List of Tables (63 Tables)

TABLE 1.  MARKET, By Product, 2021-2030 (USD Million)

TABLE 2.  MARKET FOR Thoracolumbar Devices, BY REGION, 2021-2030 (USD Million)

TABLE 3.  MARKET FOR Cervical Fixation Devices, BY REGION, 2021-2030 (USD Million)

TABLE 4.  MARKET FOR Interbody Fusion Devices, BY REGION, 2021-2030 (USD Million)

TABLE 5. MARKET, By Disease Type, 2021-2030 (USD Million)

TABLE 6. MARKET FOR Degenerative Disc, BY REGION, 2021-2030 (USD Million)

TABLE 7. MARKET FOR Complex Deformity, BY REGION, 2021-2030 (USD Million)

TABLE 8. MARKET FOR Trauma & Fractures, BY REGION, 2021-2030 (USD Million)

TABLE 9. MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 10. MARKET, BY END-USER, 2021-2030 (USD Million)

TABLE 11. MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 12. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million)

TABLE 13. MARKET FOR Specialty Clinics, BY REGION, 2021-2030 (USD Million)

TABLE 14. MARKET, BY Surgery, 2021-2030 (USD Million)

TABLE 15. MARKET FOR Open Spine Surgery, BY REGION, 2021-2030 (USD Million)

TABLE 16. MARKET FOR Minimally Invasive Spine Surgery, BY REGION, 2021-2030 (USD Million)

TABLE 17. MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 18. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 19. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million)

TABLE 20. NORTH AMERICA MARKET, By Disease Type, 2021-2030 (USD Million)

TABLE 21. NORTH AMERICA MARKET, BY END-USER, 2021-2030 (USD Million)

TABLE 22. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 23. EUROPE MARKET, By Product, 2021-2030 (USD Million)

TABLE 24. EUROPE MARKET, By Disease Type, 2021-2030 (USD Million)

TABLE 25. EUROPE MARKET, BY END-USER, 2021-2030 (USD Million)

TABLE 26. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 27. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million)

TABLE 28. ASIA-PACIFIC MARKET, By Disease Type, 2021-2030 (USD Million)

TABLE 29. ASIA-PACIFIC MARKET, BY END-USER, 2021-2030 (USD Million)

TABLE 30. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 31. LAMEA MARKET, By Product, 2021-2030 (USD Million)

TABLE 32. LAMEA MARKET, By Surgery, 2021-2030 (USD Million)

TABLE 33. LAMEA MARKET, BY END-USER, 2021-2030 (USD Million)

TABLE 34. DePuy Synthes: COMPANY SNAPSHOT

TABLE 35. DePuy Synthes: OPERATING SEGMENTS

TABLE 36. Stryker: COMPANY SNAPSHOT

TABLE 37. Stryker: OPERATING SEGMENTS

TABLE 38. Zimmer Biomet: COMPANY SNAPSHOT

TABLE 39. Zimmer Biomet: OPERATING SEGMENTS

TABLE 40. Orthofix Medical, Inc: COMPANY SNAPSHOT

TABLE 41. Orthofix Medical, Inc: OPERATING SEGMENTS

TABLE 42. B. Braun Melsungen AG: COMPANY SNAPSHOT

TABLE 43. B. Braun Melsungen AG: OPERATING SEGMENTS

TABLE 44. Medtronic: COMPANY SNAPSHOT

TABLE 45. Medtronic: OPERATING SEGMENTS

TABLE 46. NuVasive, Inc: COMPANY SNAPSHOT

TABLE 47. NuVasive, Inc: OPERATING SEGMENTS

TABLE 48. Globus Medical: COMPANY SNAPSHOT

TABLE 49. Globus Medical: OPERATING SEGMENTS

TABLE 50. ATEC Spine, Inc: COMPANY SNAPSHOT

TABLE 51. ATEC Spine, Inc: OPERATING SEGMENTS

TABLE 52. Captiva Spine, Inc: COMPANY SNAPSHOT

TABLE 53. Captiva Spine, Inc: OPERATING SEGMENTS

TABLE 54. SeaSpine: COMPANY SNAPSHOT

TABLE 55. SeaSpine: OPERATING SEGMENTS

TABLE 56. Spinal Elements, Inc: COMPANY SNAPSHOT

TABLE 57. Spinal Elements, Inc: OPERATING SEGMENTS

TABLE 58. Spine Wave, Inc: COMPANY SNAPSHOT

TABLE 59. Spine Wave, Inc: OPERATING SEGMENTS

TABLE 60. Spineology, Inc: COMPANY SNAPSHOT

TABLE 61. Spineology, Inc: OPERATING SEGMENTS

TABLE 62. Xtant Medical Holdings, Inc: COMPANY SNAPSHOT

TABLE 63. Xtant Medical Holdings, Inc: OPERATING SEGMENTS

 

List of Figures (24 Figures)

Figure 1 Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries: Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Market: Product-Based Estimation

Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Spinal Fusion Devices Market, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Spinal Fusion Devices Market, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By Disease Type, 2019 vs. 2025 (USD Million)

Figure 12 Market Share, By End-user, 2019 vs. 2025 (USD Million)

Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million)

Figure 14 Market Share, By Surgery, 2019 vs. 2025 (USD Million)

Figure 15 Geographical Snapshot of the Market

Figure 16 Thoracolumbar Devices to Witness Higher CAGR in Market for Product Segment during Forecast Period.

Figure 17 Hospitals to Witness Higher CAGR in Market for End-user Segment during Forecast Period.

Figure 18 Degenerative Disc to Witness Higher CAGR in the Market for Disease Type Segment during Forecast Period.

Figure 19 Minimally Invasive Spine Surgery to Witness Higher CAGR in Market for Surgery Segment during Forecast Period.

Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges

Figure 22 North America: Market Snapshot

Figure 23 Asia Pacific: Market Snapshot

Figure 24 Vendor Dive: Evaluation Overview